Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Observing Patients Online: the changing face of research

Nexus, Sep 2011, Pages: 47


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

For years, patients have shouted to be heard. But as online patient communities, chat rooms and forums have gained popularity—and political clout—their voices are resonating.

Now being used to paint real-world pictures of patient drug use, data from online patient communities can no longer be ignored or dismissed. “The history of medicine is that in many respects patients have been left out of the conversation,” says Brian Loew, president of inspire.com. “I think patient communities are a real opportunity to fix that.”

Already, data from online patient communities are being used to deepen understanding of the patient journey through illness, thus improving compliance, informing patient-centred endpoints for clinical trials and influencing reimbursement decisions. Such pools of patients are also being deployed to conduct direct-to-patient clinical research, where patients are recruited and monitored online, thus eliminating the need for clinical sites and investigators. In the face of payer skepticism, however, the question is how fast will it scale up?

Report Overview

In Observing Patients Online: the changing face of research, FirstWord investigates the role online patient communities can play in observational research to enhance knowledge of how drugs are taken in the real world. Based on expert interviews, research and studies, the report examines how the means to recruit patients online and track their experience via patient-reported outcome questionnaires and sensors in real-time has the potential to transform how observational studies are conducted.

Key features

- Who takes the lead in commissioning observational research

- Typical studies being commissioned online

- How healthcare tracking is going mainstream

- Case study of UCB's partnership with PatientsLikeMe

- Benefits of crowdsourcing: is it the new serendipity?

- The drivers of online observational research

Key Benefits

- Overview of how online patient communities are transforming observational research

- Access to expert opinion from key leaders in the industry

- Discussion of conventional versus direct-to-patient trials

Key Questions Asked

- What role do online patient forums have to play in observational research?

- How is pharma research using patient communities?

- What position do payers take?

- How can data mined from online sources increase the authenticity of a drug's value?

- What role, if any, does self-tracking have in observational research?

Who Should Read This Report

- E-business/Emerging Technology Directors

- Clinical Research and Trials Directors

- Heads of Communications/PR

- Market Access Directors/Managers

- Marketing Research/Business Intelligence Managers

Key quotes

“We see a shift wherein patients are not just taking part in their care, but defining it. Patients make decisions about managing their disease, defining their quality of life and deciding how their dollars are spent.”
– Brian Loew, President of inspire.com

“The challenge for the pharma industry is to identify the most effective means of communicating patients' perception of treatment benefits to the different stakeholders in a changing technological climate.”
– Mike Baldwin, Health Outcomes Manager at Novartis, UK

“At present, around 99 percent of all trials are still recruited via clinician sites. The idea of doing research directly with patients is definitely an emerging innovation. It has been piloted and now the question is how fast it will scale.”
– Elisa Cascade, Vice President of Mediguard



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds